Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 815

1.

An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.

Stockl K, Ory C, Vanderplas A, Nicklasson L, Lyness W, Cobden D, Chang E.

Curr Med Res Opin. 2007 Jan;23(1):133-46.

PMID:
17257475
3.

Preference and resource utilization in elderly patients: InnoLet versus vial/syringe.

Shelmet J, Schwartz S, Cappleman J, Peterson G, Skovlund S, Lytzen L, Nicklasson L, Liang J, Lyness W; InnoLet Study Group.

Diabetes Res Clin Pract. 2004 Jan;63(1):27-35.

PMID:
14693410
4.
5.
8.
9.

Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes.

Hayes RP, Muchmore D, Schmitke J.

Curr Med Res Opin. 2007 Feb;23(2):435-42.

PMID:
17288697
10.

Preference for insulin delivery systems among current insulin users and nonusers.

Summers KH, Szeinbach SL, Lenox SM.

Clin Ther. 2004 Sep;26(9):1498-505.

PMID:
15531012
11.
14.

Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.

Ahmann A, Szeinbach SL, Gill J, Traylor L, Garg SK.

Diabetes Technol Ther. 2014 Feb;16(2):76-83. doi: 10.1089/dia.2013.0172. Epub 2013 Nov 23.

PMID:
24266497
15.

Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization.

Davis EM, Christensen CM, Nystrom KK, Foral PA, Destache C.

Am J Health Syst Pharm. 2008 Jul 15;65(14):1347-57. doi: 10.2146/ajhp070636.

PMID:
18593681
16.

Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe.

Baser O, Bouchard J, DeLuzio T, Henk H, Aagren M.

Adv Ther. 2010 Feb;27(2):94-104. doi: 10.1007/s12325-010-0009-6. Epub 2010 Mar 26.

PMID:
20352392
18.

Preference for a new prefilled insulin pen compared with the original pen.

Garg S, Bailey T, DeLuzio T, Pollom D.

Curr Med Res Opin. 2011 Dec;27(12):2323-33. doi: 10.1185/03007995.2011.630721. Epub 2011 Oct 31.

PMID:
21988614
19.

Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.

Reimer T, Hohberg C, Pfützner AH, Jørgensen C, Jensen KH, Pfützner A.

Clin Ther. 2008 Dec;30(12):2252-62. doi: 10.1016/j.clinthera.2008.12.004.

PMID:
19167585
20.

Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.

Kadiri A, Chraibi A, Marouan F, Ababou MR, el Guermai N, Wadjinny A, Kerfati A, Douiri M, Bensouda JD, Belkhadir J, Arvanitis Y.

Diabetes Res Clin Pract. 1998 Jul;41(1):15-23.

PMID:
9768368

Supplemental Content

Support Center